Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...

PACS Group, Inc. and HealthEquity are sporting Zacks Ranks of #2 (Buy) and #3 (Hold), respectively, right now. This means that PACS's earnings estimate revision activity has been more impressive, so ...

Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and HealthEquity (HQY). But which of these two stocks offers value investors ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

HealthEquity (HQY) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.60 per share a year ago.

RBC Capital analyst Sean Dodge reiterated a Buy rating on Healthequity (HQY – Research Report) today and set a price target of $105.00. The company’s shares closed yesterday at $101.00.

Fiscal 2026 Adjusted EBITDA Margin Guidance: 41.5% to 42.5% of revenue. HealthEquity Inc (NASDAQ:HQY) reported double-digit year-over-year growth in key metrics, including a 21% increase in revenue ...

HealthEquity (HQY) reported $300.43 million in revenue for the quarter ended October 2024, representing a year-over-year increase of 20.6%. EPS of $0.78 for the same period compares to $0.60 a year ...